Colonic bacterial metabolism of corticosteroids

Vipul Yadav, Simon Gaisford, Hamid A Merchant, Abdul W Basit

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The aim of this study was to investigate the stability of four corticosteroids in the presence of human colonic bacteria to understand better their luminal behaviour when delivered orally in the treatment of inflammatory bowel disease. The stability of prednisolone, budesonide, beclometasone (17, 21) dipropionate (BDP) and its active metabolite, beclometasone-17-monopropionate (17-BMP), were investigated at three different concentrations following incubation in a mixed faecal inoculum (simulated human colonic fluid) under anaerobic conditions. Prednisolone, at all three concentrations, was completely degraded within 3 h. The degradation of budesonide progressed at a slower rate, with complete degradation occurring within 7h; the degradation of the S epimer of budesonide was faster than the R epimer. BDP degraded completely within 2 h while its active metabolite 17-BMP was comparatively stable. In contrast to the results in the faecal inoculum, all molecules were stable in the simulated colonic fluid in the absence of human faeces (control). This study demonstrates that prednisolone, BDP and budesonide are completely metabolized in simulated human colonic fluid and confirms the role of colonic bacteria in the metabolism of corticosteroids.

Original languageEnglish
Pages (from-to)268-274
Number of pages7
JournalInternational Journal of Pharmaceutics
Volume457
Issue number1
DOIs
Publication statusPublished - 30 Nov 2013
Externally publishedYes

Fingerprint

Budesonide
Adrenal Cortex Hormones
Prednisolone
Beclomethasone
Bacteria
Inflammatory Bowel Diseases
Feces
beclomethasone 17-monopropionate

Cite this

Yadav, Vipul ; Gaisford, Simon ; Merchant, Hamid A ; Basit, Abdul W. / Colonic bacterial metabolism of corticosteroids. In: International Journal of Pharmaceutics. 2013 ; Vol. 457, No. 1. pp. 268-274.
@article{d3ebe4c0b9b440febddcf66c4a541ca3,
title = "Colonic bacterial metabolism of corticosteroids",
abstract = "The aim of this study was to investigate the stability of four corticosteroids in the presence of human colonic bacteria to understand better their luminal behaviour when delivered orally in the treatment of inflammatory bowel disease. The stability of prednisolone, budesonide, beclometasone (17, 21) dipropionate (BDP) and its active metabolite, beclometasone-17-monopropionate (17-BMP), were investigated at three different concentrations following incubation in a mixed faecal inoculum (simulated human colonic fluid) under anaerobic conditions. Prednisolone, at all three concentrations, was completely degraded within 3 h. The degradation of budesonide progressed at a slower rate, with complete degradation occurring within 7h; the degradation of the S epimer of budesonide was faster than the R epimer. BDP degraded completely within 2 h while its active metabolite 17-BMP was comparatively stable. In contrast to the results in the faecal inoculum, all molecules were stable in the simulated colonic fluid in the absence of human faeces (control). This study demonstrates that prednisolone, BDP and budesonide are completely metabolized in simulated human colonic fluid and confirms the role of colonic bacteria in the metabolism of corticosteroids.",
keywords = "Colonic stability, Corticosteroids, Degradation, Human fecal slurry, Microbiota, Simulated colonic fluid",
author = "Vipul Yadav and Simon Gaisford and Merchant, {Hamid A} and Basit, {Abdul W}",
note = "Copyright {\circledC} 2013 Elsevier B.V. All rights reserved.",
year = "2013",
month = "11",
day = "30",
doi = "10.1016/j.ijpharm.2013.09.007",
language = "English",
volume = "457",
pages = "268--274",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1",

}

Colonic bacterial metabolism of corticosteroids. / Yadav, Vipul; Gaisford, Simon; Merchant, Hamid A; Basit, Abdul W.

In: International Journal of Pharmaceutics, Vol. 457, No. 1, 30.11.2013, p. 268-274.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Colonic bacterial metabolism of corticosteroids

AU - Yadav, Vipul

AU - Gaisford, Simon

AU - Merchant, Hamid A

AU - Basit, Abdul W

N1 - Copyright © 2013 Elsevier B.V. All rights reserved.

PY - 2013/11/30

Y1 - 2013/11/30

N2 - The aim of this study was to investigate the stability of four corticosteroids in the presence of human colonic bacteria to understand better their luminal behaviour when delivered orally in the treatment of inflammatory bowel disease. The stability of prednisolone, budesonide, beclometasone (17, 21) dipropionate (BDP) and its active metabolite, beclometasone-17-monopropionate (17-BMP), were investigated at three different concentrations following incubation in a mixed faecal inoculum (simulated human colonic fluid) under anaerobic conditions. Prednisolone, at all three concentrations, was completely degraded within 3 h. The degradation of budesonide progressed at a slower rate, with complete degradation occurring within 7h; the degradation of the S epimer of budesonide was faster than the R epimer. BDP degraded completely within 2 h while its active metabolite 17-BMP was comparatively stable. In contrast to the results in the faecal inoculum, all molecules were stable in the simulated colonic fluid in the absence of human faeces (control). This study demonstrates that prednisolone, BDP and budesonide are completely metabolized in simulated human colonic fluid and confirms the role of colonic bacteria in the metabolism of corticosteroids.

AB - The aim of this study was to investigate the stability of four corticosteroids in the presence of human colonic bacteria to understand better their luminal behaviour when delivered orally in the treatment of inflammatory bowel disease. The stability of prednisolone, budesonide, beclometasone (17, 21) dipropionate (BDP) and its active metabolite, beclometasone-17-monopropionate (17-BMP), were investigated at three different concentrations following incubation in a mixed faecal inoculum (simulated human colonic fluid) under anaerobic conditions. Prednisolone, at all three concentrations, was completely degraded within 3 h. The degradation of budesonide progressed at a slower rate, with complete degradation occurring within 7h; the degradation of the S epimer of budesonide was faster than the R epimer. BDP degraded completely within 2 h while its active metabolite 17-BMP was comparatively stable. In contrast to the results in the faecal inoculum, all molecules were stable in the simulated colonic fluid in the absence of human faeces (control). This study demonstrates that prednisolone, BDP and budesonide are completely metabolized in simulated human colonic fluid and confirms the role of colonic bacteria in the metabolism of corticosteroids.

KW - Colonic stability

KW - Corticosteroids

KW - Degradation

KW - Human fecal slurry

KW - Microbiota

KW - Simulated colonic fluid

U2 - 10.1016/j.ijpharm.2013.09.007

DO - 10.1016/j.ijpharm.2013.09.007

M3 - Article

VL - 457

SP - 268

EP - 274

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1

ER -